DSCAM and breast carcinoma: Over the next 2 years, DSCAM‐AS1 was found to play important roles in luminal breast cancer.9, 10 While DSCAM‐AS1 is highly expressed in ER+ and HER‐2 overexpressed breast cancer cell lines, it is mainly enriched in luminal breast cancer samples.